ArticleDiabetes, obesity & metabolism2019

Comment on "Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non-SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 diabetes mellitus: A real-world meta-analysis of 4 observational databases (OBSERVE-4D)".

Patrick B Ryan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.